Pirkko Tamsen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pirkko tamsen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pirkko Tamsen Today - Breaking & Trending Today
Nasdaq Nordic: Nasdaq Stockholm Welcomes OncoZenge to the Nasdaq First North Growth Market Stockholm, February 12, 2020 - Nasdaq (Nasdaq: NDAQ) announces that trading in OncoZenge AB s shares (short name ONCOZ) commences today on Nasdaq First North Growth Market. The company belongs to the Health Care segment. OncoZenge is the 8th company to be admitted to trading on Nasdaq s Nordic markets in 2021. Oncozenge develops superior products for cancer supportive care. OncoZenge is a Swedish pharmaceutical company founded in 2020 originating from a collaboration between Moberg Pharma and leading clinicians from Hvidovre Hospital in Denmark. BupiZenge can radically improve quality of life for patients with severe oral ....
Share this article STOCKHOLM, Jan. 29, 2021 /PRNewswire/ On November 16, 2020, OncoZenge AB (publ), Moberg Pharma s subsidiary, announced that the company had secured financing of a total of approximately SEK 70 million ahead of the spin-off and separate listing on Nasdaq First North Growth Market. Today, the Board of Moberg Pharma has decided that the record date for the right to receive shares in OncoZenge shall be February 5, 2021. The Board of OncoZenge has today, with the support of an authorization from an Extraordinary General Meeting on January 21, 2021, decided on the terms for the rights issue of approximately SEK 60 million (the Rights Issue ). In addition, an indicative timetable for both the Rights Issue and the listing process on Nasdaq First North Growth Market is announced, where the first day of trading is expected to be on February 12, 2021. ....
/PRNewswire/ OncoZenge AB (publ), Moberg Pharma s subsidiary, today announced that the European Patent Office (EPO) has granted patent 3 284 459 which. ....
OncoZenge expands the board with Hilde Furberg Search jobs OncoZenge expands the board with Hilde Furberg OncoZenge AB (publ) (“OncoZenge”), Moberg Pharma AB (publ)’s subsidiary, has at an Extraordinary Shareholders Meeting today resolved on expanding the board with Hilde Furberg ahead of the listing on Nasdaq First North Growth Market, which is planned to take place during the first quarter of 2021. Hilde Furberg (born 1958) represents Linc AB and is an independent consultant and a professional board member. She has broad senior leadership experience, coming from her over 35 years in sales, marketing, strategy and general management roles in pharmaceuticals and biotechnology. Her experience is in different areas of specialty care, and from small to large global companies. Hilde has worked in companies like Baxter and Genzyme, and she was most recently the European Head of Rare Diseases for Sanofi Genzyme. Hilde has also been a boa ....
OncoZenge raises MSEK 10 ahead of spin-off and separate listing pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.